Robot-assisted oncologic pelvic surgery with Hugo™ robot-assisted surgery system : A single-center experience
Territo, Angelo (Fundació Puigvert)
Uleri, Alessandro (Fundació Puigvert)
Gallioli, Andrea (Institut d'Investigació Biomèdica Sant Pau)
Gaya, Josep Maria (Fundació Puigvert)
Verri, Paolo (Fundació Puigvert)
Basile, Giuseppe (Fundació Puigvert)
Farré Martinez, Alba (Fundació Puigvert)
Bravo-Balado, Alejandra (Fundació Puigvert)
Tedde, Alessandro (Fundació Puigvert)
Rodríguez Faba, Óscar (Institut d'Investigació Biomèdica Sant Pau)
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau)
Breda, Alberto (Institut d'Investigació Biomèdica Sant Pau)
Universitat Autònoma de Barcelona

Date:	2023
Abstract:	To report the outcomes of intra- and extra-peritoneal robot-assisted radical prostatectomy (RARP) and robot-assisted radical cystectomy (RARC) with Hugo™ robot-assisted surgery (RAS) system (Medtronic, Minneapolis, MN, USA). Data of twenty patients who underwent RARP and one RARC at our institution between February 2022 and January 2023 were reported. The primary endpoint of the study was to report the surgical setting of Hugo™ RAS system to perform RARP and RARC. The secondary endpoint was to assess the feasibility of RARP and RARC with this novel robotic platform and report the outcomes. Seventeen patients underwent RARP with a transperitoneal approach, and three with an extraperitoneal approach; and one patient underwent RARC with intracorporeal ileal conduit. No intraoperative complications occurred. Median docking and console time were 12 (interquartile range [IQR] 7-16) min and 185 (IQR 177-192) min for transperitoneal RARP, 15 (IQR 12-17) min and 170 (IQR 162-185) min for extraperitoneal RARP. No intraoperative complications occurred. One patient submitted to extraperitoneal RARP had a urinary tract infection in the postoperative period that required an antibiotic treatment (Clavien-Dindo Grade 2). In case of transperitoneal RARP, two minor complications occurred (one pelvic hematoma and one urinary tract infection; both Clavien-Dindo Grade 2). Hugo™ RAS system is a novel promising robotic platform that allows to perform major oncological pelvic surgery. We showed the feasibility of RARP both intra- and extra-peritoneally and RARC with intracorporeal ileal conduit with this novel platform.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Bladder cancer ; Prostate cancer ; Radical cystectomy ; Radical prostatectomy ; Robotic surgery
Published in:	Asian Journal of Urology, Vol. 10 Núm. 4 (october 2023) , p. 461-466, ISSN 2214-3890

DOI: 10.1016/j.ajur.2023.05.003
PMID: 38024434

6 p, 1.3 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles